Citigroup’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,000
Closed -$150K 6596
2022
Q1
$150K Buy
+5,000
New +$135K ﹤0.01% 4225
2020
Q4
Sell
-1,050
Closed -$25K 7599
2020
Q3
$25K Buy
1,050
+660
+169% +$16.2K ﹤0.01% 6032
2020
Q2
$7K Buy
+390
New +$7.02K ﹤0.01% 7184
2020
Q1
Sell
-170
Closed -$4K 7756
2019
Q4
$4K Sell
170
-50
-23% -$1.03K ﹤0.01% 7460
2019
Q3
$4K Sell
220
-160
-42% -$3.31K ﹤0.01% 7403
2019
Q2
$10K Sell
380
-120
-24% -$2.71K ﹤0.01% 7311
2019
Q1
$13K Sell
500
-130
-21% -$2.97K ﹤0.01% 7152
2018
Q4
$14K Buy
630
+290
+85% +$8.18K ﹤0.01% 7040
2018
Q3
$11K Sell
340
-450
-57% -$13.5K ﹤0.01% 7327
2018
Q2
$22K Sell
790
-190
-19% -$6.76K ﹤0.01% 6873
2018
Q1
$35K Buy
980
+440
+81% +$17.6K ﹤0.01% 6413
2017
Q4
$21K Buy
540
+380
+238% +$14.5K ﹤0.01% 6714
2017
Q3
$4K Sell
160
-150
-48% -$3.65K ﹤0.01% 6907
2017
Q2
$8K Buy
310
+50
+19% +$1.37K ﹤0.01% 6605
2017
Q1
$9K Buy
260
+160
+160% +$4.08K ﹤0.01% 6601
2016
Q4
$2K Buy
+100
New +$2.86K ﹤0.01% 7065

Other funds holding RIGL